Published in Exp Aging Res on May 30, 2003
Substance and tongue-region specific loss in basic taste-quality identification in elderly adults. Eur Arch Otorhinolaryngol (2006) 0.86
Taste loss in hospitalized multimorbid elderly subjects. Clin Interv Aging (2013) 0.85
Taste intensity in the Beaver Dam Offspring Study. Laryngoscope (2013) 0.85
Can age-related CNS taste differences be detected as early as middle age? Evidence from fMRI. Neuroscience (2012) 0.78
Recalled taste intensity, liking and habitual intake of commonly consumed foods. Appetite (2016) 0.75
Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. J Am Geriatr Soc (2008) 1.46
Predicting non-completion of treatment for latent tuberculous infection: a prospective survey. Am J Respir Crit Care Med (2006) 1.45
Cortical activation in response to pure taste stimuli during the physiological states of hunger and satiety. Neuroimage (2008) 1.40
Altered processing of sweet taste in the brain of diet soda drinkers. Physiol Behav (2012) 1.15
Involvement of consumers in studies run by the Medical Research Council Clinical Trials Unit: results of a survey. Trials (2012) 1.11
Clinical evaluation and symptoms of chemosensory impairment: one thousand consecutive cases from the Nasal Dysfunction Clinic in San Diego. Am J Rhinol (2006) 1.09
Reduced nucleus accumbens and caudate nucleus activation to a pleasant taste is associated with obesity in older adults. Brain Res (2011) 1.08
The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer's disease, probable Alzheimer's disease, and healthy elderly controls. J Clin Exp Neuropsychol (2004) 1.05
Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. J Am Soc Nephrol (2007) 1.02
Regional variations in chronic rhinosinusitis, 2003-2006. Otolaryngol Head Neck Surg (2009) 1.01
Males and females show differential brain activation to taste when hungry and sated in gustatory and reward areas. Appetite (2011) 1.00
Olfactory assessment using the NIH Toolbox. Neurology (2013) 1.00
FMRI brain activation in response to odors is reduced in primary olfactory areas of elderly subjects. Brain Res (2003) 0.97
On-line psychophysical data acquisition and event-related fMRI protocol optimized for the investigation of brain activation in response to gustatory stimuli. J Neurosci Methods (2006) 0.97
Apolipoprotein epsilon4 is associated with more rapid decline in odor identification than in odor threshold or Dementia Rating Scale scores. Brain Cogn (2004) 0.96
Olfactory event-related potentials in Alzheimer's disease. J Int Neuropsychol Soc (2002) 0.94
Validation of a stimulation protocol suited to the investigation of odor-taste interactions with fMRI. Physiol Behav (2004) 0.93
Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy. J Med Chem (2008) 0.92
Neural substrates of cross-modal olfactory recognition memory: an fMRI study. Neuroimage (2006) 0.92
Olfactory impairment in adults. Ann N Y Acad Sci (2009) 0.90
Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease. J Clin Exp Neuropsychol (2007) 0.89
Central structures necessary and sufficient for ingestive and glycemic responses to Urocortin I administration. J Neurosci (2004) 0.89
The effect of hormone therapy on olfactory sensitivity is dependent on apolipoprotein E genotype. Horm Behav (2008) 0.88
Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells. J Gene Med (2009) 0.87
1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonists. Bioorg Med Chem Lett (2005) 0.86
Olfactory, auditory, and visual ERPs from single trials: no evidence for habituation. Int J Psychophysiol (2004) 0.86
Differences between recognition memory and remote memory for olfactory and visual stimuli in nondemented elderly individuals genetically at risk for Alzheimer's disease. Exp Gerontol (2004) 0.86
Age-related functional changes in gustatory and reward processing regions: An fMRI study. Neuroimage (2010) 0.86
Addressing parental concerns about pain during childhood vaccination: is there enough time to include pain management in the ambulatory setting? Clin J Pain (2012) 0.86
The cerebellum and olfaction in the aging brain: a functional magnetic resonance imaging study. Neuroimage (2003) 0.85
Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor. Biochemistry (2005) 0.85
Olfactory acuity and cognitive function converge in older adulthood: support for the common cause hypothesis. Psychol Aging (2002) 0.84
Apolipoprotein E epsilon4 genotype and gender: effects on memory. Am J Geriatr Psychiatry (2007) 0.84
Circadian rhythm and desensitization in chemosensory event-related potentials in response to odorous and painful stimuli. Psychophysiology (2003) 0.84
Differences in olfactory and visual memory in patients with pathologically confirmed Alzheimer's disease and the Lewy body variant of Alzheimer's disease. J Int Neuropsychol Soc (2004) 0.83
Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists. Bioorg Med Chem (2008) 0.83
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 2. Reduction of hERG activity, observed species selectivity, and structure-activity relationships. J Med Chem (2008) 0.83
Olfactory dysfunction: a sequela of pediatric blunt head trauma. Int J Pediatr Otorhinolaryngol (2005) 0.83
Age-related differences in the neural substrates of cross-modal olfactory recognition memory: an fMRI investigation. Brain Res (2009) 0.83
Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activity. Bioorg Med Chem (2007) 0.83
Laterality of the olfactory event-related potential response. Chem Senses (2006) 0.83
Semantic networks for odors and colors in Alzheimer's disease. Neuropsychology (2010) 0.83
An update on nutrition support in the critically ill. J Pharm Pract (2010) 0.83
Body weight regulation by selective MC4 receptor agonists and antagonists. Ann N Y Acad Sci (2003) 0.82
Differential effects of normal aging on memory for odor-place and object-place associations. Exp Aging Res (2008) 0.82
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituents. J Med Chem (2008) 0.82
Olfactory impairment increases as a function of age in persons with Down syndrome. Neurobiol Aging (2001) 0.82
Effects of the ApoE epsilon4 allele on olfactory function in Down syndrome. J Alzheimers Dis (2004) 0.82
Functional connectivity during recognition memory in individuals genetically at risk for Alzheimer's disease. Hum Brain Mapp (2011) 0.82
True and false recognition memories of odors induce distinct neural signatures. Front Hum Neurosci (2011) 0.81
MC4 receptor antagonists: a potential treatment for cachexia. IDrugs (2005) 0.80
Risk factors for aminoglycoside-associated nephrotoxicity in surgical intensive care unit patients. Int J Crit Illn Inj Sci (2011) 0.80
Pyrrolidinones as potent functional antagonists of the human melanocortin-4 receptor. Bioorg Med Chem Lett (2007) 0.80
Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonists. Bioorg Med Chem Lett (2008) 0.79
Differential effects of active attention and age on event-related potentials to visual and olfactory stimuli. Int J Psychophysiol (2010) 0.79
The effects of normal aging on source memory for odors. J Gerontol B Psychol Sci Soc Sci (2006) 0.79
Estrogen and performance in recognition memory for olfactory and visual stimuli in females diagnosed with Alzheimer's disease. J Int Neuropsychol Soc (2006) 0.79
Education level predicts retrospective metamemory accuracy in healthy aging and Alzheimer's disease. J Clin Exp Neuropsychol (2013) 0.79
Developmental differences in memory for cross-modal associations. Dev Sci (2009) 0.78
Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptor. J Med Chem (2007) 0.78
Olfactory and auditory event-related potentials in Huntington's disease. Neuropsychology (2005) 0.78
N-[6-amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A2A receptor antagonists with improved drug like properties and in vivo efficacy. J Med Chem (2009) 0.78
Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor. Bioorg Med Chem Lett (2007) 0.78
The effect of stimulus delivery technique on perceived intensity functions for taste stimuli: implications for fMRI studies. Atten Percept Psychophys (2009) 0.78
Restrained eaters show altered brain response to food odor. Physiol Behav (2006) 0.78
Eyeblink classical conditioning to auditory and olfactory stimuli: performance among older adults with and without the apolipoprotein E epsilon 4 allele. Neuropsychology (2005) 0.77
Olfactory ERPs in an odor/visual congruency task differentiate ApoE ε4 carriers from non-carriers. Brain Res (2011) 0.77
Epidemiological studies of smell: discussion and perspectives. Ann N Y Acad Sci (2009) 0.77
Age and apolipoprotein E ε4 effects on neural correlates of odor memory. Behav Neurosci (2013) 0.77
Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's disease. J Med Chem (2008) 0.77
N-glycosylation is important for the correct intracellular localization of HFE and its ability to decrease cell surface transferrin binding. FEBS J (2010) 0.77
A paradigm for measuring the olfactory event-related potential in the clinic. Int J Psychophysiol (2003) 0.77
Abnormal event-related potentials in young and middle-aged adults with the ApoE ε4 allele. Int J Psychophysiol (2011) 0.77
Source and item memory for odors and objects in children and young adults. Dev Neuropsychol (2006) 0.77
Impaired odor identification in children with histories of heavy prenatal alcohol exposure. Alcohol (2013) 0.77
Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazines. Bioorg Med Chem Lett (2005) 0.77
A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic properties. J Med Chem (2006) 0.77
Reliability analysis of event-related brain potentials to olfactory stimuli. Psychophysiology (2002) 0.76
Utility of olfactory identification test for diagnosing Chinese patients with Alzheimer's disease. J Clin Exp Neuropsychol (2002) 0.76
Effect of encoding condition on source memory for odors in healthy young and older adults. Gerontology (2008) 0.76
A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice. Bioorg Med Chem Lett (2005) 0.76
Nasal health in Down syndrome: a cross-sectional study. Otolaryngol Head Neck Surg (2006) 0.76
Toxin-induced chemosensory dysfunction: a case series and review. Am J Rhinol Allergy (2009) 0.76
Improvement of fMRI data processing of olfactory responses with a perception-based template. Neuroimage (2004) 0.76
Synthesis and characterization of pyrrolidine derivatives as potent agonists of the human melanocortin-4 receptor. Bioorg Med Chem Lett (2007) 0.76
Individuals at risk for Alzheimer's disease show differential patterns of ERP brain activation during odor identification. Behav Brain Funct (2012) 0.75
Performance of older Japanese American adults on selected cognitive instruments. J Int Neuropsychol Soc (2013) 0.75
Smell impairment. Postgrad Med (1995) 0.75
The community practicum: an opportunity to synthesize learning for emerging practices. Occup Ther Health Care (2003) 0.75
614: ANTICOAGULATION IN PATIENTS WITH AN ALTERED HEPARIN RESPONSE. Crit Care Med (2016) 0.75